The Patent Finder

Mutant Peptides And Methods Of Treating Subjects Using The Same

Prince Biotech, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 62/211,660, filed Aug 28, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,096,987Mutant Peptides And Methods Of Treating Subjects Using The Same
In force
 · Medium confidence
Prince Biotech, LLCIn force
Medium confidence
US 12,458,681Compositions and Method for Treating Acute Radiation Syndrome
In force
 · Medium confidence
Prince Biotech, LLCIn force
Medium confidence
Application 17/379,987Mutant Peptides And Methods Of Treating Subjects Using The Same
Abandoned
Abandoned Jan 30, 2025
Prince Biotech, LLCAbandonedAbandoned Jan 30, 2025
Application 17/472,574Compositions and Methods for Treating Acute Radiation Syndrome
Abandoned
Abandoned Sep 23, 2023
Prince Biotech, LLCAbandonedAbandoned Sep 23, 2023
Application 17/651,064Pif Binding as a Marker for Immune Dysregulation
Pending
Not granted
Prince Biotech, LLCPendingNot granted
Application 18/957,407Mutant Peptides And Methods Of Treating Subjects Using The Same
Pending
Not granted
Prince Biotech, LLCPendingNot granted
Application 19/376,749Compositions and Methods for Treating Acute Radiation Syndrome
Pending
Not granted
Prince Biotech, LLCPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Prince Biotech, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited